Cargando…
Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphoma
Objective: This phase Ia study was designed to assess the pharmacokinetic (PK) characters of free vincristine (F-VCR, refer to as non-liposomal VCR and VCR released from liposome) and total vincristine (T-VCR, the sum of both liposomal VCR and F-VCR), urinary excretion and safety of intravenous admi...
Autores principales: | Yang, Fen, Jiang, Min, Lu, Ming, Hu, Pei, Wang, Hongyun, Jiang, Ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123375/ https://www.ncbi.nlm.nih.gov/pubmed/30210349 http://dx.doi.org/10.3389/fphar.2018.00991 |
Ejemplares similares
-
Marqibo(®) (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
por: Silverman, Jeffrey A., et al.
Publicado: (2012) -
Vincristine sulfate liposomal injection for acute lymphoblastic leukemia
por: Raj, Trisha A Soosay, et al.
Publicado: (2013) -
Vincristine sulfate liposomal injection for acute lymphoblastic leukemia [Corrigendum]
Publicado: (2013) -
The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate
por: Zhang, Jing, et al.
Publicado: (2016) -
Clinical Pharmacokinetics and Effects of Vincristine Sulfate in Dogs with
Transmissible Venereal Tumor (TVT)
por: HANTRAKUL, Supannika, et al.
Publicado: (2014)